Nursing Elites

1. What is the primary effect of a calcium channel blocker on the heart?

• A. Decreases heart rate
• B. Increases heart rate
• C. Increases blood pressure
• D. Decreases blood pressure

Correct answer: D

Rationale: The correct answer is D: Decreases blood pressure. Calcium channel blockers primarily work by relaxing blood vessels, leading to a decrease in blood pressure. While these medications can have secondary effects on the heart, such as reducing the workload of the heart muscle, the primary effect related to blood pressure regulation. Therefore, choices A, B, and C are incorrect as they do not reflect the primary action of calcium channel blockers on the heart.

2. Which of the following is a chronic lung disease that results in the gradual destruction of the alveoli, causing difficulty breathing and reduced oxygen exchange?

• A. Emphysema
• B. Bronchitis
• C. Pulmonary hypertension
• D. Sarcoidosis

Correct answer: A

Rationale: Emphysema is the correct answer as it is a chronic lung disease characterized by the gradual destruction of the alveoli, which are essential for oxygen exchange. This destruction leads to difficulty breathing and reduced oxygen levels in the blood. Bronchitis is an inflammation of the bronchial tubes, not specifically involving alveoli destruction. Pulmonary hypertension is a condition of high blood pressure in the arteries of the lungs, not directly related to alveoli destruction. Sarcoidosis is a disease characterized by the growth of tiny collections of inflammatory cells in different parts of the body, including the lungs, but it does not primarily involve the destruction of alveoli.

3. What is a condition where the walls of the arteries become thickened and stiff, often due to the buildup of plaque, leading to reduced blood flow?

• A. Atherosclerosis
• B. Angina
• C. Hypertension
• D. Arrhythmia

Correct answer: A

Rationale: Atherosclerosis is the correct answer. It is a condition characterized by the thickening and stiffening of artery walls due to plaque buildup, which restricts blood flow. Angina (choice B) is chest pain or discomfort caused by reduced blood flow to the heart. Hypertension (choice C) is high blood pressure, not directly related to arterial wall thickening. Arrhythmia (choice D) refers to irregular heart rhythms and is not specifically linked to artery wall changes like atherosclerosis.

4. Which condition is characterized by a chronic cough that produces mucus, often caused by long-term exposure to irritants?

• A. Chronic bronchitis
• B. Tuberculosis
• C. Asthma
• D. Sinusitis

Correct answer: A

Rationale: Chronic bronchitis is the correct answer. It is characterized by a long-term cough with mucus production, often caused by smoking or prolonged exposure to irritants. Tuberculosis (choice B) is a bacterial infection that primarily affects the lungs but does not usually present with a chronic cough as the main symptom. Asthma (choice C) is a chronic respiratory condition characterized by inflammation and narrowing of the airways, leading to wheezing and shortness of breath, but it does not typically cause chronic mucus production. Sinusitis (choice D) is inflammation of the sinuses and presents with symptoms like facial pain, nasal congestion, and post-nasal drip, but not specifically a chronic cough with mucus production.

5. The client is on spironolactone (Aldactone) and has a potassium level of 5.9 mEq/L. What is the nurse’s priority action?

• A. Hold the spironolactone and notify the healthcare provider.
• B. Administer potassium supplements.
• C. Continue the spironolactone as ordered.
• D. Increase the dose of spironolactone.

Correct answer: A

Rationale: The correct answer is A: Hold the spironolactone and notify the healthcare provider. A potassium level of 5.9 mEq/L is high, indicating hyperkalemia. Spironolactone is a potassium-sparing diuretic that can further increase potassium levels. Therefore, the priority action is to hold the medication to prevent exacerbating hyperkalemia and notify the healthcare provider for further guidance. Choice B is incorrect because administering potassium supplements would worsen hyperkalemia. Choice C is incorrect because continuing spironolactone could lead to a further increase in potassium levels. Choice D is incorrect because increasing the dose of spironolactone would exacerbate the hyperkalemia.

Similar Questions